These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3522734)

  • 1. Macrophage-mediated fungistasis: requirement for a macromolecular component in serum.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jul; 137(2):693-701. PubMed ID: 3522734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jan; 136(2):672-80. PubMed ID: 3510251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine.
    Brummer E; Stevens DA
    Cell Immunol; 1994 Aug; 157(1):1-10. PubMed ID: 8039240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
    Coleman DL; Root RK; Ryan JL
    J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
    Murray HW; Spitalny GL; Nathan CF
    J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.
    Brummer E; Gilmore GL; Shadduck RK; Stevens DA
    Cell Immunol; 1998 Nov; 189(2):144-8. PubMed ID: 9790728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.
    Leu RW; Rummage JA; Horn MJ
    Immunobiology; 1989 Feb; 178(4-5):340-50. PubMed ID: 2469639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide.
    Kawakami K; Zhang T; Qureshi MH; Saito A
    Cell Immunol; 1997 Aug; 180(1):47-54. PubMed ID: 9316638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate.
    Cameron ML; Granger DL; Weinberg JB; Kozumbo WJ; Koren HS
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1313-9. PubMed ID: 2123614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages.
    Weinberg PB; Becker S; Granger DL; Koren HS
    Am Rev Respir Dis; 1987 Nov; 136(5):1242-7. PubMed ID: 3314617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.
    Granger DL; Hibbs JB; Perfect JR; Durack DT
    J Clin Invest; 1988 Apr; 81(4):1129-36. PubMed ID: 3280600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth regulation of a murine lymphoma cell line by a 2-mercaptoethanol or macrophage-activated serum factor.
    Hewlett G; Opitz HG; Schlumberger HD; Lemke H
    Eur J Immunol; 1977 Nov; 7(11):781-5. PubMed ID: 304005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and purification of mouse macrophage procoagulant-inducing factor.
    Ryan J; Geczy CL
    J Immunol; 1986 Nov; 137(9):2864-70. PubMed ID: 3760575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of iron on peritoneal macrophage activity and sperm phagocytosis in rats].
    Skowron J
    Ann Acad Med Stetin; 2000; 46():63-75. PubMed ID: 11712318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro.
    Reardon CC; Kim SJ; Wagner RP; Kornfeld H
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):711-5. PubMed ID: 8969264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.